EFFECT OF ISOFLAVONE ON HUMAN ENDOMETRIAL CANCER CELL LINES IN VITRO

  • MIYAMOTO Shingo
    Department of Obstetrics and Gynecology, Showa University School of Medicine
  • YANAIHARA Atsushi
    Department of Obstetrics and Gynecology, Showa University School of Medicine
  • MITSUKAWA Kaori
    Department of Obstetrics and Gynecology, Showa University School of Medicine
  • NAGATSUKA Masaki
    Department of Obstetrics and Gynecology, Showa University School of Medicine
  • OKAI Takashi
    Department of Obstetrics and Gynecology, Showa University School of Medicine

Bibliographic Information

Other Title
  • イソフラボンのヒト子宮内膜癌細胞株増殖能に対する効果
  • イソフラボン ノ ヒト シキュウナイマク ガン サイボウシュ ゾウショクノウ ニ タイスル コウカ

Search this article

Abstract

The objective of this study was to examine the action of isoflavone on human endometrial cells. We determined the effect of a daidzein-rich isoflavone aglycone mixture (Dr. AglyMax®) on the growth of hormone-dependent endometrial cancer cells (ISHIKAWA cell) in vitro. ISHIKAWA cells were plated into 96-well micoplates, treated with Dr. AglyMaxTM, and incubated for 24h. Cell proliferation was analyzed by ELISA using specific antibodies. We compared cell proliferation between Dr. AglyMax®at a concentration of 100 μM and a control without Dr. AglyMax®. Total RNA was isolated from cultured cells by the acid guanidine thiocyanatephenol/chloroform method. We also examined the changes in approximately 47, 000 gene expressions using a microarray method. Cell proliferation of the Dr. AglyMax®-treated group was lower than that of the control group (67%) (p<0.01) . A total of 1165 genes were down-regulated and 1114 genes were up-regurated following treatment with 100 iM Dr. AglyMax® . Our study suggests that daidzein-rich isoflavone aglycones inhibit endometrial cell growth and these genes, which are involved in steroid metabolism and cell cycles, are likely related to inhibition of cancer cell growth.

Journal

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top